EXPO

Business Context and Reporting Period

Company: Exponent, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 28, 2002
Business Overview: Exponent is a science and engineering consulting firm providing solutions to complex problems across environmental, health, and litigation support sectors. The company operates on a 52-53 week fiscal calendar.

Key Financial Metrics

Note: Debt figures represent current installments of long-term obligations plus long-term obligations net of current installments.

Material Changes vs. Prior Period

• Revenue Growth: Q2 2002 revenue increased 14.1% year-over-year, driven by higher billable hours, increased billing rates, and the acquisition of Novigen Sciences, Inc. (contributing $562,000 in Q2 revenue).
• Profitability: Operating income surged 148% in Q2 2002 compared to Q2 2001. Net income increased 123% for the quarter and 20% for the six-month period.
• Expense Management: General and administrative expenses decreased 19.4% in Q2, primarily due to the cessation of goodwill amortization following the adoption of SFAS No. 142 and reduced recruiting costs.
• Cash Flow: Operating cash flow turned positive, providing $4.6 million in the first six months of 2002, compared to a use of $4.7 million in the same period in 2001. This shift was driven by improved accounts receivable collections.
• Segment Performance: The "Environmental and Health" segment grew 20.7% in Q2, while "Other Scientific and Engineering" grew 11.9%. Growth in the latter was partially offset by a $2.5 million decrease in the Land Warrior program (pre-production phase).

Guidance, Outlook, and Risks

• Acquisition Impact: The acquisition of Novigen Sciences, Inc. for $2.1 million cash and $725,000 in stock is expected to increase compensation expenses by approximately $2.5 million in fiscal 2002.
• Cost Savings: Staff reductions in technology development and vehicle analysis practices are expected to yield approximately $1 million in cost savings for fiscal 2002.
• Land Warrior Program: Revenues from this program are expected to remain at reduced levels through the remainder of 2002 as it is in the pre-production phase.
• Real Estate: Rental income from the Silicon Valley facility remains reduced as a large tenant vacated in January 2001; management anticipates rental income will continue at this reduced level if the space remains unleased.
• Tax Rate: The effective tax rate for the first six months of 2002 was 48.0%, higher than the prior year, due to an expiring capital loss carry-forward write-off and expectations of higher tax rates on future income.
• Risks: Key risks include the absence of a reliable backlog, customer concentration (transportation and government sectors), competition, and the cyclical nature of the economy.

Investor Verification Checklist

• Goodwill Accounting: Verify the impact of SFAS No. 142 adoption on reported earnings and the $1.9 million goodwill recorded from the Novigen acquisition.
• Land Warrior Revenue: Monitor the trajectory of the Land Warrior program revenues, which are currently depressed due to the pre-production phase.
• Real Estate Utilization: Assess the status of leasing the vacant 24,000 sq. ft. space in the Silicon Valley facility to determine if rental income will recover.
• Customer Concentration: Review the dependency on transportation industry and government clients, as the loss of a major client could materially impact results.
• Acquisition Integration: Track the integration of Novigen Sciences and the realization of projected synergies versus the $2.5 million increase in compensation costs.